Ellen Berg, Ph.D., Chief Scientific Officer

Dr. Berg has over 18 years of research experience in pathophysiologic mechanisms of inflammation and immunity. Her expertise in complex cell-based biological assays led to the development of the company's proprietary BioMAP^® technology for rapid target and lead validation. Prior to founding BioSeek, Inc., Dr. Berg was at Protein Design Labs, Inc. where she was involved in the discovery and development of therapeutic antibodies for treatment of inflammatory diseases. Dr. Berg holds a Ph.D. from Northwestern University and was a postdoctoral fellow at Stanford University where she was supported by fellowships from the American Cancer Society and the Stanford Cancer Biology Program, and served as a Special Fellow of the Leukemia Society of America. Dr. Berg holds several patents in the fields of inflammation biology and cell adhesion and has authored over 50 publications in peer-reviewed journals.